| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/13/2008 | CA2661102A1 Thiophene derivatives as s1p1/edg1 receptor agonists |
| 03/13/2008 | CA2653696A1 Recombinant vaccine against bluetongue virus |
| 03/12/2008 | EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 03/12/2008 | EP1897870A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient |
| 03/12/2008 | EP1897557A1 Use of glycolipids as adjuvants |
| 03/12/2008 | EP1897556A1 Prevention and treatment of hypergastrinemia |
| 03/12/2008 | EP1897553A1 Inhibitor of stem cell proliferation and uses thereof |
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP1896507A2 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 03/12/2008 | EP1896453A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 03/12/2008 | EP1896446A1 Novel thiophene derivatives |
| 03/12/2008 | EP1896080A2 Toxin peptides with extended blood halflife |
| 03/12/2008 | EP1896055A1 Immune disease medicament comprising a modulator of the binding between a heparin binding domain of thrombospondin-1 and a beta1 integrin |
| 03/12/2008 | EP1896035A2 Carbazole formulations for the treatment of psoriasis and angiogenesis |
| 03/12/2008 | EP1896012A2 Anti-inflammatory agents |
| 03/12/2008 | EP1745780A4 Medicinal preparation |
| 03/12/2008 | EP1705182A4 Antitumoral and antiviral peptides |
| 03/12/2008 | EP1594896B1 Modified soluble t cell receptor |
| 03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
| 03/12/2008 | EP1495009B1 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 03/12/2008 | EP1427395B1 Stabilization of active agents by formulation into nanoparticulate form |
| 03/12/2008 | EP1414809B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/12/2008 | EP1265648B1 NOVEL collagen-BASED MATERIAL WITH IMPROVED PROPERTIES FOR USE IN HUMAN AND VETERINARY MEDICINE AND THE METHOD OF MANUFACTURING SUCH |
| 03/12/2008 | EP1220680B1 Echinacea supplement and method of manufacture |
| 03/12/2008 | EP1210434B1 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 03/12/2008 | EP0876487B1 Mammalian cx3c chemokine genes |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN101142218A Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 03/12/2008 | CN101142196A Ligands for G-protein coupled receptors |
| 03/12/2008 | CN101141979A Cat allergen conjugates and uses thereof |
| 03/12/2008 | CN101141974A Protein introducing carrier, protein introducing agent given by using the carrier, method for introducing the protein, protein introduced cell, and method for producing the cell |
| 03/12/2008 | CN101141970A Use of 5'-methylthioadenosine (MTA) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection |
| 03/12/2008 | CN101141967A Novel use of ligands specific to fex-2 polypeptide |
| 03/12/2008 | CN101139554A Solid-state fermentation preparing method for Chinese herbal medicine yeast selenium |
| 03/12/2008 | CN101139343A Synthesis of piperidine and piperazine compounds as ccr5 antagonists |
| 03/12/2008 | CN101138566A Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds |
| 03/12/2008 | CN100374568C TAO protein kinases and methods of use thereof |
| 03/12/2008 | CN100374466C Antibodies against human IL-12 |
| 03/12/2008 | CN100374457C Anti-IL-6 antibodies, compositions, methods and uses |
| 03/12/2008 | CN100374416C P-(sulfonyl)-aryl and heteroaryls amines |
| 03/12/2008 | CN100374152C Hypersensitivity reaction inhibitor |
| 03/12/2008 | CN100374125C Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn |
| 03/12/2008 | CN100374111C Composition for preventing or treating allergic disease using black rice extract and its therapeutic use |
| 03/12/2008 | CN100374085C Method and apparatus for production of a skin graft and the graft produced thereby |
| 03/11/2008 | US7342125 Administering derivatives of Kauranoic acid; cachexia, analgesics, in treating immune disorders, as anti-cancer and anti-tumor agents, otitis media, sinusitis, antidiabetic agent |
| 03/11/2008 | US7342106 Human antihuman MCP-1 antibody and antibody fragment thereof |
| 03/11/2008 | US7342045 Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same |
| 03/11/2008 | US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/11/2008 | US7342029 Substituted indoles |
| 03/11/2008 | US7342021 Phosphodiesterase 4 inhibitors |
| 03/11/2008 | US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists |
| 03/11/2008 | US7342002 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy |
| 03/11/2008 | US7341870 Dendritic cell line |
| 03/11/2008 | US7341860 Regulated antigen delivery system (RADS) |
| 03/11/2008 | US7341746 Chinese herbs extract |
| 03/11/2008 | US7341732 Methods for treating mastitis in a milk producing animal |
| 03/11/2008 | US7341729 Recombinant parainfluenza virus expression systems and vaccines |
| 03/11/2008 | US7341723 Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide |
| 03/11/2008 | CA2413087C Suplatast tosilate crystals |
| 03/11/2008 | CA2335104C Arylalkanoylpyridazines |
| 03/11/2008 | CA2290646C Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| 03/08/2008 | CA2601358A1 Method for inducing mucosal humoral and cell-mediated immune responses by sublingual administration of antigens |
| 03/06/2008 | WO2008028192A2 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 03/06/2008 | WO2008027812A2 Imidazopyridine and imidazopyrimidine derivatives |
| 03/06/2008 | WO2008027584A2 5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase |
| 03/06/2008 | WO2008026781A1 Reverse targeting lipid vesicle |
| 03/06/2008 | WO2008026776A1 Transdermal composition, transdermal pharmaceutical composition and transdermal cosmetic composition comprising polymer micelle encapsulating active ingredient |
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008026687A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 03/06/2008 | WO2008026334A1 Agent for inhibiting intestinal permeation of allergen |
| 03/06/2008 | WO2008025822A1 Diazolodiazine derivatives as kinase inhibitors |
| 03/06/2008 | WO2008025821A1 Triazole derivatives as kinase inhibitors |
| 03/06/2008 | WO2008025820A1 Aminopyridine derivates as kinase inhibitors |
| 03/06/2008 | WO2008025512A1 Pyrrolo isoquinolines as kinase inhibitors |
| 03/06/2008 | WO2008025171A1 Vaccines and methods for treatment or prevention of salmonella spp. bacterial infection in a vertebrate subject |
| 03/06/2008 | WO2008011110A3 Di-amino-substituted heterocyclic compounds and methods of use |
| 03/06/2008 | WO2008008549A3 Combination of an immunosuppressive agent and nonsteroidal anti -inflammatory drugs to treat neoplasia |
| 03/06/2008 | WO2008006795A3 Indole compounds |
| 03/06/2008 | WO2007131154A3 Using naltrexone as a multi-purpose health supplement to improve the human condition and preventing multiple diseases and infirmities by stimulating immune system vitality and robustness |
| 03/06/2008 | WO2007100643A3 Methods of using antibodies against human il-22 |
| 03/06/2008 | WO2007080404A3 Leptin ligand |
| 03/06/2008 | WO2007061907A3 High-potency sweetener composition for treatment and/or prevention of autoimmune disorders and compositions sweetened therewith |
| 03/06/2008 | US20080058369 Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors |
| 03/06/2008 | US20080058357 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 03/06/2008 | US20080058354 Treating erectile dysfunction and female sexual dysfunction; side effect reduction; 1-ethyl-3-(2-hydroxyethyl)-7-(3-bromo-4-methoxyphenyl)-8-(2-hydroxycyclopenylamino)-1,2,3,6-tetrahydro-7H-purine-2,6-dione for example |
| 03/06/2008 | US20080058350 Imidazopyridine and imidazopyrimidine derivatives |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058335 Pain, inflammatory or immune disorders, neurological disorders, cancers of the immune system, respiratory disorders, cardiovascular disorders, neuroprotection; e.g. 5-chloro-N-[(2Z)-5-(1-hydroxy-1-methylethyl)-3-[((cis)-3-methoxycyclobutyl)methyl]-4-methyl-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide |
| 03/06/2008 | US20080058325 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 03/06/2008 | US20080058308 2-carbonylamino-4,6-dihydrothieno[2,3-c]furans such as ethyl 2-{[2-fluoro-6-(trifluoromethyl)benzoyl]amino}-4-methyl-4,6-dihydrothieno[2,3-c]furan-3-carboxylate; CB2 receptors ligands for immune and inflammatory conditions; pain; neuroprotectants |
| 03/06/2008 | US20080058303 Antiinflammatory agents |
| 03/06/2008 | US20080058271 Dtection of autoantigen; diagnosis, therapy of autoimmune disease |
| 03/06/2008 | US20080058267 Combinatorial therapy; genetic engineered protein; therapy for autoimmune diaeses; anticancer agents |
| 03/06/2008 | US20080057565 Method for overexpression of zwitterionic polysaccharides |
| 03/06/2008 | US20080057537 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057109 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
| 03/06/2008 | US20080057083 Protecting an animal against a pathogen by administering protective agent which is able to stimulate the animal's immune system to produce a response which is protective against the pathogen, and an immunostimulant comprising a polycationic carbohydrate or derivative thereof; non-parenteral immunization |
| 03/06/2008 | US20080057076 Novel fibroblast growth factors |
| 03/06/2008 | US20080057073 Methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; using reovirus for treatment of cellular proliferative disorders, particularly wherein proliferating cells exhibit constitutive MAPK phosphorylation in mammals; antitumor agents |